These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1676990)

  • 21. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
    Eitner K; Reinicke C; Hippius M
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orocecal transit time in patients with celiac disease from North India: a case control study.
    Rana SV; Sharma S; Sinha SK; Prasad KK; Bhasin DK; Singh K
    Trop Gastroenterol; 2008; 29(2):98-100. PubMed ID: 18972770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the breath hydrogen test to assess the effect of age on orocecal transit time and carbohydrate assimilation in cats.
    Papasouliotis K; Sparkes AH; Gruffydd-Jones TJ; Cripps PJ; Harper EJ
    Am J Vet Res; 1998 Oct; 59(10):1299-302. PubMed ID: 9781465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).
    van Hees PA; Tuinte JH; van Rossum JM; van Tongeren JH
    Gut; 1979 Apr; 20(4):300-4. PubMed ID: 36332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of association between body size and large intestinal transit time in healthy dogs.
    Hernot DC; Dumon HJ; Biourge VC; Martin LJ; Nguyen PG
    Am J Vet Res; 2006 Feb; 67(2):342-7. PubMed ID: 16454643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment].
    Guastavino E; Litwin NH; Heffes Nahmod L; Licastro R
    Acta Gastroenterol Latinoam; 1988; 18(2):107-13. PubMed ID: 2908013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of yacon (Smallanthus sonchifolius) on colonic transit time in healthy volunteers.
    Geyer M; Manrique I; Degen L; Beglinger C
    Digestion; 2008; 78(1):30-3. PubMed ID: 18781073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.
    Bharucha AE; Seide B; Guan Z; Andrews CN; Zinsmeister AR
    Neurogastroenterol Motil; 2008 Jun; 20(6):643-8. PubMed ID: 18312543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of colonic transit using a delayed-release capsule containing radio-opaque markers.
    Park JM; Choi MG; Choi H; Cho YK; Oh JH; Lee IS; Kim SW; Choi KY; Chung IS
    Scand J Gastroenterol; 2008; 43(5):545-50. PubMed ID: 18415746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
    Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of arginine-vasopressin on stool output and gastrointestinal transit time in healthy volunteers.
    Voderholzer WA; Klauser AG; Mühldorfer BE; Fiedler F; Müller-Lissner SA
    Z Gastroenterol; 1995 Apr; 33(4):189-92. PubMed ID: 7793116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An HPLC assay for sulphapyridine in plasma and its use to assess small bowel transit time after the administration of sulphasalazine.
    Staniforth DH; Coates P; Clarke JG
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):406-9. PubMed ID: 2887521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteers.
    Bergmann JF; Chaussade S; Couturier D; Baumer P; Schwartz JC; Lecomte JM
    Aliment Pharmacol Ther; 1992 Jun; 6(3):305-13. PubMed ID: 1350927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scintigraphic evaluation of small bowel transit in healthy subjects: inter- and intrasubject variability.
    Argenyi EE; Soffer EE; Madsen MT; Berbaum KS; Walkner WO
    Am J Gastroenterol; 1995 Jun; 90(6):938-42. PubMed ID: 7771425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple and simultaneous determination of sulphapyridine and acetylsulphapyridine in human serum by column-switching high-performance liquid chromatography.
    Teshima D; Hino B; Itoh Y; Oishi R
    J Clin Pharm Ther; 2002 Dec; 27(6):403-8. PubMed ID: 12472979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the pig a good animal model for studying the human ileal brake?
    Dobson CL; Hinchcliffe M; Davis SS; Chauhan S; Wilding IR
    J Pharm Sci; 1998 May; 87(5):565-8. PubMed ID: 9572906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oro-caecal transit time in man assessed by the sulfasalazine/sulfapyridine test. Correlation between plasma-saliva appearance of sulfapyridine.
    Dhôte R; Leglise P; Bergmann JF; Conort O; Caulin C
    Fundam Clin Pharmacol; 1992; 6(8-9):383-5. PubMed ID: 1363408
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration.
    Shaffer JL; Houston JB
    Br J Clin Pharmacol; 1985 Apr; 19(4):526-8. PubMed ID: 2859874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.